{"name": "Genelabs Technologies",
 "permalink": "genelabs-technologies",
 "crunchbase_url": "http://www.crunchbase.com/company/genelabs-technologies",
 "homepage_url": "http://www.genelabs.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": 76,
 "founded_year": 1983,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "650-369-9500",
 "description": "",
 "created_at": "Thu Sep 10 11:36:58 UTC 2009",
 "updated_at": "Mon Apr 29 14:08:04 UTC 2013",
 "overview": "\u003Cp\u003EAs of January 6, 2009, Genelabs Technologies Inc. was acquired by SmithKline Beecham Corporation. Genelabs Technologies, Inc., a biopharmaceutical company, engages in the discovery and development of infectious disease therapies to improve human health. The company\u00e2\u20ac\u2122s product pipeline consists of infectious disease projects focusing on Hepatitis C virus infection; and late-stage clinical assets, including an investigational vaccine for hepatitis E virus that is being developed by GlaxoSmithKline; and Prestara, an investigational drug for systemic lupus erythematosus. It has license and collaboration agreement with the Novartis Institutes for BioMedical Research for HCV polymerase non-nucleoside discovery research. Genelabs Technologies also has a collaborative research agreement with the National Health Research Institutes and Genovate Biotechnology Co., Ltd. to discover and develop compounds that target the hepatitis C virus. The company was founded in 1983 and is headquartered in Redwood City, California.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       39],
      "assets/images/resized/0005/9344/59344v1-max-150x150.jpg"],
     [[162,
       43],
      "assets/images/resized/0005/9344/59344v1-max-250x250.jpg"],
     [[162,
       43],
      "assets/images/resized/0005/9344/59344v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "Executive Chairman",
    "person":
     {"first_name": "Irene",
      "last_name": "A. Chow",
      "permalink": "irene-a-chow",
      "image":
       {"available_sizes":
         [[[110,
            150],
           "assets/images/resized/0025/5935/255935v1-max-150x150.jpg"],
          [[184,
            250],
           "assets/images/resized/0025/5935/255935v1-max-250x250.jpg"],
          [[200,
            271],
           "assets/images/resized/0025/5935/255935v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Member Of The Board Of Directors",
    "person":
     {"first_name": "Leslie",
      "last_name": "J. Browne",
      "permalink": "leslie-j-browne",
      "image":
       {"available_sizes":
         [[[104,
            140],
           "assets/images/resized/0025/5952/255952v1-max-150x150.jpg"],
          [[104,
            140],
           "assets/images/resized/0025/5952/255952v1-max-250x250.jpg"],
          [[104,
            140],
           "assets/images/resized/0025/5952/255952v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Director \u0026 Member Of The Board Of Directors",
    "person":
     {"first_name": "Alan",
      "last_name": "Y. Kwan",
      "permalink": "alan-y-kwan",
      "image": null}},
   {"is_past": false,
    "title": "Member Of The Board Of Directors",
    "person":
     {"first_name": "H.",
      "last_name": "H. Haight",
      "permalink": "h-h-haight",
      "image": null}},
   {"is_past": false,
    "title": "Member Of The Board Of Directors",
    "person":
     {"first_name": "Matthew",
      "last_name": "J. Pfeffer",
      "permalink": "matthew-j-pfeffer",
      "image":
       {"available_sizes":
         [[[150,
            150],
           "assets/images/resized/0025/5995/255995v1-max-150x150.jpg"],
          [[200,
            200],
           "assets/images/resized/0025/5995/255995v1-max-250x250.jpg"],
          [[200,
            200],
           "assets/images/resized/0025/5995/255995v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": true,
    "title": "Chairman",
    "person":
     {"first_name": "Irene",
      "last_name": "A. Chow",
      "permalink": "irene-a-chow",
      "image":
       {"available_sizes":
         [[[110,
            150],
           "assets/images/resized/0025/5935/255935v1-max-150x150.jpg"],
          [[184,
            250],
           "assets/images/resized/0025/5935/255935v1-max-250x250.jpg"],
          [[200,
            271],
           "assets/images/resized/0025/5935/255935v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": true,
    "title": "Co - Founder ",
    "person":
     {"first_name": "Edgar",
      "last_name": "G. Engleman",
      "permalink": "edgar-g-engleman",
      "image":
       {"available_sizes":
         [[[150,
            150],
           "assets/images/resized/0025/5657/255657v1-max-150x150.jpg"],
          [[176,
            176],
           "assets/images/resized/0025/5657/255657v1-max-250x250.jpg"],
          [[176,
            176],
           "assets/images/resized/0025/5657/255657v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": true,
    "title": "President \u0026 CEO",
    "person":
     {"first_name": "Irene",
      "last_name": "A. Chow",
      "permalink": "irene-a-chow",
      "image":
       {"available_sizes":
         [[[110,
            150],
           "assets/images/resized/0025/5935/255935v1-max-150x150.jpg"],
          [[184,
            250],
           "assets/images/resized/0025/5935/255935v1-max-250x250.jpg"],
          [[200,
            271],
           "assets/images/resized/0025/5935/255935v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": true,
    "title": "CFO",
    "person":
     {"first_name": "Fredrick",
      "last_name": "W. Driscoll",
      "permalink": "fredrick-w-driscoll",
      "image":
       {"available_sizes":
         [[[112,
            150],
           "assets/images/resized/0025/5847/255847v1-max-150x150.jpg"],
          [[150,
            200],
           "assets/images/resized/0025/5847/255847v1-max-250x250.jpg"],
          [[150,
            200],
           "assets/images/resized/0025/5847/255847v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": true,
    "title": "Vice President, Business Development",
    "person":
     {"first_name": "Roy",
      "last_name": "J. Wu",
      "permalink": "roy-j-wu",
      "image":
       {"available_sizes":
         [[[150,
            150],
           "assets/images/resized/0025/5920/255920v1-max-150x150.png"],
          [[180,
            180],
           "assets/images/resized/0025/5920/255920v1-max-250x250.png"],
          [[180,
            180],
           "assets/images/resized/0025/5920/255920v1-max-450x450.png"]],
        "attribution": ""}}},
   {"is_past": true,
    "title": "VP, Medical Affairs",
    "person":
     {"first_name": "Kenneth",
      "last_name": "E. Schwartz",
      "permalink": "kenneth-e-schwartz",
      "image":
       {"available_sizes":
         [[[150,
            150],
           "assets/images/resized/0025/5893/255893v1-max-150x150.jpg"],
          [[200,
            200],
           "assets/images/resized/0025/5893/255893v1-max-250x250.jpg"],
          [[200,
            200],
           "assets/images/resized/0025/5893/255893v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": true,
    "title": "VP, Research",
    "person":
     {"first_name": "Ronald",
      "last_name": "C. Griffith",
      "permalink": "ronald-c-griffith",
      "image":
       {"available_sizes":
         [[[150,
            150],
           "assets/images/resized/0025/5864/255864v1-max-150x150.jpg"],
          [[200,
            200],
           "assets/images/resized/0025/5864/255864v1-max-250x250.jpg"],
          [[200,
            200],
           "assets/images/resized/0025/5864/255864v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": true,
    "title": "Chief Scientific Officer",
    "person":
     {"first_name": "Ronald",
      "last_name": "C. Griffith",
      "permalink": "ronald-c-griffith",
      "image":
       {"available_sizes":
         [[[150,
            150],
           "assets/images/resized/0025/5864/255864v1-max-150x150.jpg"],
          [[200,
            200],
           "assets/images/resized/0025/5864/255864v1-max-250x250.jpg"],
          [[200,
            200],
           "assets/images/resized/0025/5864/255864v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": true,
    "title": "V P, General Counsel, Corporate Secretary",
    "person":
     {"first_name": "Clint",
      "last_name": "Webb",
      "permalink": "clint-webb",
      "image":
       {"available_sizes":
         [[[100,
            100],
           "assets/images/resized/0025/5899/255899v1-max-150x150.jpg"],
          [[100,
            100],
           "assets/images/resized/0025/5899/255899v1-max-250x250.jpg"],
          [[100,
            100],
           "assets/images/resized/0025/5899/255899v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": true,
    "title": "Director",
    "person":
     {"first_name": "Matthew",
      "last_name": "J. Pfeffer",
      "permalink": "matthew-j-pfeffer",
      "image":
       {"available_sizes":
         [[[150,
            150],
           "assets/images/resized/0025/5995/255995v1-max-150x150.jpg"],
          [[200,
            200],
           "assets/images/resized/0025/5995/255995v1-max-250x250.jpg"],
          [[200,
            200],
           "assets/images/resized/0025/5995/255995v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": true,
    "title": "Vice President, Biological Sciences",
    "person":
     {"first_name": "Amy",
      "last_name": "K. Patick",
      "permalink": "amy-k-patick",
      "image":
       {"available_sizes":
         [[[150,
            120],
           "assets/images/resized/0025/5873/255873v1-max-150x150.jpg"],
          [[250,
            200],
           "assets/images/resized/0025/5873/255873v1-max-250x250.jpg"],
          [[300,
            240],
           "assets/images/resized/0025/5873/255873v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": true,
    "title": "Independent Director",
    "person":
     {"first_name": "Leslie",
      "last_name": "J. Browne",
      "permalink": "leslie-j-browne",
      "image":
       {"available_sizes":
         [[[104,
            140],
           "assets/images/resized/0025/5952/255952v1-max-150x150.jpg"],
          [[104,
            140],
           "assets/images/resized/0025/5952/255952v1-max-250x250.jpg"],
          [[104,
            140],
           "assets/images/resized/0025/5952/255952v1-max-450x450.jpg"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$17.3M",
 "funding_rounds":
  [{"round_code": "unattributed",
    "source_url": "http://www.thefreelibrary.com/Genelabs+Technologies+Raises+$9+Million+in+Private+Placement+Financing-a0147670948",
    "source_description": "Genelabs Technologies Raises $9 Million in Private Placement Financing.",
    "raised_amount": 9000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2007,
    "funded_month": 6,
    "funded_day": 30,
    "investments":
     []},
   {"round_code": "unattributed",
    "source_url": "",
    "source_description": "EDGAR",
    "raised_amount": 8300000.0,
    "raised_currency_code": "USD",
    "funded_year": 2006,
    "funded_month": 6,
    "funded_day": 27,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "RA Capital Management",
         "permalink": "ra-capital-management",
         "image":
          {"available_sizes":
            [[[150,
               37],
              "assets/images/resized/0008/4805/84805v2-max-150x150.png"],
             [[230,
               58],
              "assets/images/resized/0008/4805/84805v2-max-250x250.png"],
             [[230,
               58],
              "assets/images/resized/0008/4805/84805v2-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Fort Mason Capital",
         "permalink": "fort-mason-capital",
         "image": null},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Centrecourt Asset Management",
         "permalink": "centrecourt-asset-management",
         "image":
          {"available_sizes":
            [[[150,
               34],
              "assets/images/resized/0008/4806/84806v1-max-150x150.jpg"],
             [[250,
               56],
              "assets/images/resized/0008/4806/84806v1-max-250x250.jpg"],
             [[295,
               67],
              "assets/images/resized/0008/4806/84806v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Merlin Biomed",
         "permalink": "merlin-biomed",
         "image":
          {"available_sizes":
            [[[150,
               63],
              "assets/images/resized/0006/8420/68420v2-max-150x150.jpg"],
             [[244,
               104],
              "assets/images/resized/0006/8420/68420v2-max-250x250.jpg"],
             [[244,
               104],
              "assets/images/resized/0006/8420/68420v2-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Paramount BioCapital Asset Management",
         "permalink": "paramount-biocapital-asset-management",
         "image":
          {"available_sizes":
            [[[150,
               60],
              "assets/images/resized/0007/3355/73355v1-max-150x150.png"],
             [[180,
               73],
              "assets/images/resized/0007/3355/73355v1-max-250x250.png"],
             [[180,
               73],
              "assets/images/resized/0007/3355/73355v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition":
  {"price_amount": 57000000.0,
   "price_currency_code": "USD",
   "term_code": "cash",
   "source_url": "http://www.biojobblog.com/2009/01/articles/biojobbuzz/more-layoffs-gsk-completes-purchase-of-genelabs-technologies-inc/",
   "source_description": "More Layoffs: GSK Completes Purchase of Genelabs Technologies, Inc.",
   "acquired_year": 2008,
   "acquired_month": 11,
   "acquired_day": null,
   "acquiring_company":
    {"name": "GlaxoSmithKline",
     "permalink": "glaxosmithkline",
     "image":
      {"available_sizes":
        [[[150,
           51],
          "assets/images/resized/0005/1020/51020v1-max-150x150.png"],
         [[158,
           54],
          "assets/images/resized/0005/1020/51020v1-max-250x250.png"],
         [[158,
           54],
          "assets/images/resized/0005/1020/51020v1-max-450x450.png"]],
       "attribution": null}}},
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "505 Penobscot Drive",
    "address2": "",
    "zip_code": "94063-4738",
    "city": "Redwood City",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}